Adela Inc News Today

/PRNewswire/ -- Adela, Inc., an innovator in blood testing for minimal residual disease monitoring and early cancer detection through a proprietary genome-wide...

NEW HAVEN, Conn., October 12, 2023--BioCT is delighted to announce the appointment of David Scheer as Co-Chair of its Board of Directors. With a distinguished career in the life sciences industry and extensive experience in building successful companies, David brings invaluable expertise to his new leadership role within BioCT.

GUILFORD, Conn., July 12, 2023 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the appointment of David Scheer as Chairman

The multicancer early detection platform was developed based on methylation of cell-free DNA

An experimental blood test may be able to catch a dozen different types of cancer with a high degree of accuracy -- including some that are particularly tricky to detect, a preliminary study suggests.

MONDAY, April 17, 2023 (HealthDay News) -- An experimental blood test may be able to catch a dozen different types of cancer with a high degree of accuracy — including

/PRNewswire/ -- Adela, Inc., focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test, has made appointments...

/PRNewswire/ -- The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium will host a virtual liquid biopsy summit – the consortiums first – to provide an...